Slug Antibody (OTI1A6) NBP2-03886 from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemSlug Antibody (OTI1A6)
CompanyNovus Biologicals, a Bio-Techne Brand
Price $499.00Supplier Page View Company Product Page
Catalog NumberNBP2-03886
Quantity0.1 ml
ApplicationsIF/IHC,Flow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin
Conjugate/TagUnconjugated
FormatPBS (pH 7.3), 1.0% BSA and 50% Glycerol
ReactivityHuman,Mouse,Rat
ClonalityMonoclonal
TargetSlug
IsotypeIgG1
CloneOTI1A6
HostMouse
ImmunogenFull length human recombinant protein of human SNAI2 (NP_003059) produced in E.coli
PurityImmunogen affinity purified
Research AreaNeuronal Cell Markers
Molecular Weight29.8 kDa
Concentration1 mg/ml
Antibody TypePrimary Antibodies
StorageStore at -20C. Avoid freeze-thaw cycles
NCBI Full Gene Namesnail family transcriptional repressor 2
NCBI Gene AliasesSLUG, SLUGH, SLUGH1, SNAIL2, WS2D

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Sizes Available: 0.1 ml

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological CorrelationCureusJune 11, 2026M Kalaivani, Divya Dhanabal, Leena Dennis JosephNovus Biologicals, Centennial, CO, USA; 1:100 dilution), mouse monoclonal anti-SLUG antibodies (e.g., NBP2-03886, Novus Biologicals, Centennial, CO, USA; 1:200 dilution), mouse monoclonal anti-TWIST1 antibodies (e.g.,

(2) Fn14 Controls the SIRT2-Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian CancerAdvanced science (Weinheim, Baden-Wurttemberg, Germany)July 1, 2025Wu A, Li S, Feng C, He R, Wu R, Hu Z, Huang J, Wang W, Huang L, Qiu L.diluted as follows: anti‐Fn14 (1:500, no.ab109365; Abcam, Cambridge, MA, USA), anti‐Slug (1:100, no. NBP2‐03886; Novus, Littleton, CO, USA), anti‐SIRT2 (1:1000, no.NBP1‐87039; Novus), anti‐E‐cadherin (1:200, no.14472;

(3) The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinomaHistopathologyJanuary 1, 0001"Cappellesso R, Marioni G, Crescenzi M, Giacomelli L, Guzzardo V, Mussato A, Staffieri A, Martini A, Blandamura S, Fassina A."

(4) FSCN1 and epithelial mesenchymal transformation transcription factor expression in human pancreatic intraepithelial neoplasia and ductal adenocarcinoma"Pathology, research and practice"January 1, 0001"Morris HT, Bamlet WR, Razidlo GL, Machesky LM."antibodies: FSCN1 mouse monoclonal (Agilent, M3567, 1:150), SNAI2 mouse monoclonal OTIA6 (Novus Biologicals NBP2–03886, 1:400), TWIST1 mouse monoclonal 10E4E6 (Novus Biologicals NBP2–37364, 1:1000). Full details of the

(5) SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancerGeneJanuary 1, 0001"Penolazzi L, Bonaccorsi G, Gafà R, Ravaioli N, Gabriele D, Bosi C, Lanza G, Greco P, Piva R."

(6) Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinomaCell death & diseaseJanuary 1, 0001"Liu L, Deng P, Liu S, Hong JH, Xiao R, Guan P, Wang Y, Wang P, Gao J, Chen J, et al."antibody used were KI-67 (Zsbio Commerce Stor, ZA-0502), cleaved-caspase 3 (CST, 9661), SLUG (Novus, NBP2-03886) and NOTCH3 (Abcam, ab23426). Animal studies Female BALB/c nude mice (5–6 weeks) were purchased from

(7) Immunoexpression of transcription factors in urothelial bladder carcinomasRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieJanuary 1, 0001"Stepan AE, Ciurea RN, Drăgoescu PO, Florescu MM, Stepan MD."

(8) Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancersTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJanuary 1, 0001"Sadlecki P, Jóźwicki J, Antosik P, Grabiec M."(glial cells) 7 8 27 Grade + 2 + + + + 69.0 11.9 11.9 7.2 1:100 1:200 1:20 1:200 1:500 1:100 IA IB IC Other NBP1-80022 NBP2-03886 ab50887 ab57997 HPA027524 HPA003456 29 5 5 3 FIGO (stage) Novus Biologicals Novus Biologicals Abcam,

(9) Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial CancerBioMed research internationalJanuary 1, 0001"Sadłecki P, Jóźwicki J, Antosik P, Walentowicz-Sadłecka M."(1 : 100, 45 min, NBP1-80022, Novus Biologicals) antibody, mouse monoclonal anti-SLUG (1 : 200, 30 min, NBP2-03886, Novus Biologicals) antibody, mouse monoclonal anti-TWIST1 (1 : 20, 60 min, ab50887, Abcam) antibody,

(10) Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinomaJournal of cellular physiologyJanuary 1, 0001"Li SH, Qian L, Chen YH, Lu HI, Tsai HT, Lyu H, Yang R, Chen CH."

(11) Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?CancersJanuary 1, 0001"Sbiera I, Kircher S, Altieri B, Fassnacht M, Kroiss M, Sbiera S."

(12) Maxillary calcifying epithelial odontogenic tumor with sinus and buccal vestibule extension: a case report and immunohistochemical studyDiagnostic pathologyJanuary 1, 0001"Munteanu C, Pirici D, Stepan AE, Camen A, Margaritescu C."